Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin. Lu Q, Wang YY, Wang QH, Tang LN, et al. Seizure 2022;99:71-74.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu Q, Wang YY, Wang QH, Tang LN, et al. Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin. Seizure 2022;99:71-74.
PMID: 35605444